What are the recommended atropine dosing regimens for adult and pediatric symptomatic bradycardia, organophosphate poisoning, pre‑operative anticholinergic premedication, and ocular use?

Atropine Dosing Recommendations

Symptomatic Bradycardia (Adult)

For adults with symptomatic bradycardia, administer atropine 0.5–1 mg IV push immediately, repeating every 3–5 minutes as needed up to a maximum total dose of 3 mg. 1, 2

Dosing Protocol

• Initial dose: 0.5 mg IV bolus (may give up to 1 mg for severe bradycardia with HR ≈30 bpm) 3, 2
• Repeat interval: Every 3–5 minutes if bradycardia persists 1, 2
• Maximum total dose: 3 mg in most patients; limit to 2–3 mg in acute myocardial infarction to avoid tachycardia-induced ischemia 3, 1, 2
• Peak effect: Within 3 minutes of IV administration 3

Critical Dosing Warnings

• Never administer doses <0.5 mg as they can paradoxically worsen bradycardia through central vagal stimulation 3, 1, 2
• In coronary artery disease, limit total dose to 0.03–0.04 mg/kg (approximately 2–2.5 mg for a 70-kg adult) to prevent worsening ischemia 1, 2, 4
• Atropine is contraindicated in infranodal AV block (Mobitz II or third-degree with wide QRS) as it will not improve conduction and may worsen the block 1, 2

When Atropine Fails

• Dopamine infusion: 5–10 mcg/kg/min IV, titrate by 2–5 mcg/kg/min every 2 minutes, maximum 20 mcg/kg/min 1, 2
• Epinephrine infusion: 2–10 mcg/min IV, preferred when severe hypotension requires combined chronotropic and vasopressor support 1, 2
• Transcutaneous pacing: Initiate immediately in unstable patients; do not delay while giving additional atropine doses 1, 2

---

Symptomatic Bradycardia (Pediatric)

For pediatric patients, administer atropine 0.02 mg/kg IV (range 0.01–0.03 mg/kg), with a minimum single dose of 0.1 mg and maximum single dose of 0.5 mg. 1, 4

Pediatric Dosing Specifics

• Minimum dose: 0.1 mg to avoid paradoxical bradycardia 1
• Maximum single dose: 0.5 mg for children, 1.0 mg for adolescents 1
• Maximum total dose: 1 mg for children, 2 mg for adolescents 1
• Endotracheal route (if IV unavailable): 0.04–0.06 mg/kg (double to triple the IV dose), followed by 5 mL normal saline flush and 5 positive-pressure ventilations 1

---

Organophosphate/Nerve Agent Poisoning (Adult)

For organophosphate poisoning, initiate atropine 2–5 mg IV immediately, then double the dose every 20–30 minutes until full atropinization is achieved (clear chest, HR >80/min, systolic BP >80 mmHg, dry secretions). 1, 5, 6

Aggressive Dosing Protocol

• Initial dose: 2–5 mg IV bolus 1, 5
• Escalation: Double the dose every 20–30 minutes until muscarinic symptoms resolve 1, 5
• Cumulative doses: May reach 10–20 mg in the first 2–3 hours 1
• 24-hour maximum: Up to 50 mg may be required before full muscarinic antagonism appears 1, 5
• Maintenance: Continuous IV infusion after initial boluses to maintain atropinization 1, 7

Endpoints of Atropinization

• Clear chest on auscultation (no bronchorrhea or bronchospasm) 1
• Heart rate >80 bpm 1
• Systolic blood pressure >80 mmHg 1
• Drying of secretions 1

Critical Pitfall

Underdosing is more dangerous than overdosing in organophosphate poisoning—titrate aggressively to dry secretions and reverse bronchospasm without arbitrary dose limits. 1, 5, 6

---

Organophosphate Poisoning (Pediatric)

For pediatric organophosphate poisoning, administer atropine 0.05 mg/kg IV (up to adult dose of 2–5 mg), then double as needed without a defined maximum, titrated to clinical effect. 1

---

Ventricular Asystole

For ventricular asystole during cardiac arrest, administer atropine 1 mg IV, repeated every 3–5 minutes if asystole persists during CPR, up to a maximum cumulative dose of 2.5 mg over 2.5 hours. 3

---

Pre-operative Antisialagogue

For reduction of salivation and bronchial secretions before surgery, administer atropine 0.5–1 mg IV as a single dose. 4

---

Ocular Use (Cycloplegia/Mydriasis)

Atropine ophthalmic drops are administered topically for cycloplegia, mydriasis, and amblyopia treatment. 8

Important Safety Warning

Systemic absorption from ophthalmic atropine can cause anticholinergic toxicity, including stroke-like symptoms, delirium, and hallucinations, even at normal topical doses. 8

---

Special Populations & Contraindications

Heart Transplant Recipients

Atropine is contraindicated in heart-transplant patients without autonomic re-innervation, as it may precipitate high-degree AV block or sinus arrest in approximately 20% of cases; use epinephrine instead. 1, 2

Acute Coronary Syndrome

In acute MI, limit atropine to 2–3 mg total and target HR ≈60 bpm to avoid tachycardia-induced ischemia or infarct extension. 1, 2

Infranodal AV Block

Do not use atropine for Mobitz II second-degree AV block or third-degree AV block with wide QRS complex, as it will not improve conduction and may worsen the block. 1, 2

---

Administration Technique

Administer atropine as a direct IV bolus (push) without dilution for rapid administration in emergencies. 1

---

Monitoring Parameters

• Continuous ECG monitoring to assess rhythm response and detect emergent arrhythmias 1, 2
• Blood pressure and heart rate every 2–5 minutes during titration 1
• Signs of atropine toxicity: Tachycardia >100 bpm, dry mouth, blurred vision, urinary retention, delirium, hallucinations 1, 4
• In organophosphate poisoning: Resolution of miosis, bronchorrhea, and bronchospasm 1